Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (351-360 of 455) with videos related to

Pageof 46
Sort By:
Free Radical Research|May 12, 2023
Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trialsEmil List Larsen, Andreas Andersen, Laura K Kjær, et al.
Nephron|November 3, 2021
Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose MonitoringTobias Bomholt, Bo Feldt-Rasmussen, Rizwan Butt, et al.
Journal of the Endocrine Society|January 16, 2026
Glucose-Dependent Effects of Exogenous Glucagon-Like Peptide-2 on Circulating Glucagon Levels in Healthy MenNikolaj E Sørum, Tore Magnussen, Nina L Hansen, et al.
Diabetes Care|January 12, 2026
Empagliflozin in HNF1A-MODY (MODY3)-a Randomized, Double-Blind, Placebo-Controlled, Crossover TrialHenrik Maagensen, Stine O Høyerup, Johanne S Jensen, et al.
Endocrine Connections|January 26, 2024
The effect of exogenous glucagon on circulating amino acids in individuals with and without type 2 diabetes and obesityMagnus F G Grøndahl, Jonatan I Bagger, Malte P Suppli, et al.
Plos One|November 13, 2015
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose MetabolismKristian H Mikkelsen, Morten Frost, Martin I Bahl, et al.
Metabolic Syndrome and Related Disorders|October 17, 2018
Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control SubjectsMia Demant, Jonatan I Bagger, Malte P Suppli, et al.
Diabetes, Obesity & Metabolism|January 3, 2023
Exercise-related hypoglycaemia induces QTc-interval prolongation in individuals with type 1 diabetesPer G Hagelqvist, Andreas Andersen, Kaisar B Maytham, et al.
Diabetologia|January 27, 2019
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover studyNatasha C Bergmann, Asger Lund, Lærke S Gasbjerg, et al.
Clinical and Translational Gastroenterology|January 29, 2021
Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover StudyNina L Hansen, Andreas Brønden, Christina C Nexøe-Larsen, et al.
Pageof 46

Showing results (351-360 of 455) with videos related to

Sort By:
Pageof 46
Free Radical Research|May 12, 2023
Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trialsEmil List Larsen, Andreas Andersen, Laura K Kjær, et al.
Nephron|November 3, 2021
Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose MonitoringTobias Bomholt, Bo Feldt-Rasmussen, Rizwan Butt, et al.
Journal of the Endocrine Society|January 16, 2026
Glucose-Dependent Effects of Exogenous Glucagon-Like Peptide-2 on Circulating Glucagon Levels in Healthy MenNikolaj E Sørum, Tore Magnussen, Nina L Hansen, et al.
Diabetes Care|January 12, 2026
Empagliflozin in HNF1A-MODY (MODY3)-a Randomized, Double-Blind, Placebo-Controlled, Crossover TrialHenrik Maagensen, Stine O Høyerup, Johanne S Jensen, et al.
Endocrine Connections|January 26, 2024
The effect of exogenous glucagon on circulating amino acids in individuals with and without type 2 diabetes and obesityMagnus F G Grøndahl, Jonatan I Bagger, Malte P Suppli, et al.
Plos One|November 13, 2015
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose MetabolismKristian H Mikkelsen, Morten Frost, Martin I Bahl, et al.
Metabolic Syndrome and Related Disorders|October 17, 2018
Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control SubjectsMia Demant, Jonatan I Bagger, Malte P Suppli, et al.
Diabetes, Obesity & Metabolism|January 3, 2023
Exercise-related hypoglycaemia induces QTc-interval prolongation in individuals with type 1 diabetesPer G Hagelqvist, Andreas Andersen, Kaisar B Maytham, et al.
Diabetologia|January 27, 2019
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover studyNatasha C Bergmann, Asger Lund, Lærke S Gasbjerg, et al.
Clinical and Translational Gastroenterology|January 29, 2021
Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover StudyNina L Hansen, Andreas Brønden, Christina C Nexøe-Larsen, et al.
Pageof 46